G21 NUCLEONICS INC. — National Aeronautics and Space Administration SBIR Phase II: IN-SITU RADIOISOTOPE STERILIZATION FOR BACKWARD AND FORWARD CONTAMINATION - ENABLING LOW-M
G21 NUCLEONICS INC. — SBIR Phase II award from National Aeronautics and Space Administration.
Phase II SBIR prototype / development signal
- Phase II is where National Aeronautics and Space Administration funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,274,900 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Space & Satellite, Power & Energy. Follow those hubs for open topics and peer winners in the same cluster.
Summary
G21 Nucleonics Inc. received $1,274,900 from NASA for Phase II SBIR work on in-situ radioisotope sterilization. This technology helps protect planets from contamination during space missions using simple, lightweight solutions.
- Amount
- $1,274,900
- Agency
- National Aeronautics and Space Administration · National Aeronautics and Space Administration
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- WA
- Period
- 2026-09-15 → 2028-09-14
Technology domains
Description
SBIR PHASE II - IN-SITU RADIOISOTOPE STERILIZATION FOR BACKWARD AND FORWARD CONTAMINATION - ENABLING LOW-MASS, LOW-COMPLEXITY SOLUTIONS FOR PLANETARY PROTECTION